Innospec Inc. (NASDAQ: IOSP) is a Basic Materials company in the Chemicals - Specialty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 18.89 | EPS (ttm) | 4.59 | Insider Own | 1.95% | Shs Outstand | 24.63M | Perf Week | 0.93% |
| Market Cap | 2.14B | Forward P/E | 14.26 | EPS next Y | 6.08 | Insider Trans | -2.43% | Shs Float | 24.32M | Perf Month | 5.21% |
| Enterprise Value | 1.88B | PEG | 0.71 | EPS next Q | - | Inst Own | - | Short Float | 1.99% | Perf Quarter | 13.36% |
| Income | 114.00M | P/S | 1.19 | EPS this Y | 4.72% | Inst Trans | - | Short Ratio | 2.42 | Perf Half Y | 3.83% |
| Sales | 1.79B | P/B | 1.58 | EPS next Y | 26.49% | ROA | 6.28% | Short Interest | 484.89K | Perf YTD | 13.27% |
| Book/sh | 54.89 | P/C | 7.39 | EPS next 5Y | 26.49% | ROE | 8.68% | 52W High | 92.14 -5.90% | Perf Year | 10.38% |
| Cash/sh | 11.73 | P/FCF | 27.58 | EPS past 3/5Y | -4.25% 32.12% | ROIC | 8.25% | 52W Low | 65.51 32.35% | Perf 3Y | -18.05% |
| Dividend Est. | 1.84 (2.12%) | EV/EBITDA | 10.52 | Sales past 3/5Y | -3.26% 8.31% | Gross Margin | 27.41% | Volatility | 2.45% 2.29% | Perf 5Y | -0.24% |
| Dividend TTM | 1.79 (2.06%) | EV/Sales | 1.05 | EPS Y/Y TTM | 223.24% | Oper. Margin | 8.06% | ATR (14) | 2.01 | Perf 10Y | 73.57% |
| Dividend Ex-Date | May 19, 2026 | Quick Ratio | 2.02 | Sales Y/Y TTM | -2.93% | Profit Margin | 6.38% | RSI (14) | 62.09 | Recom | 2.56 |
| Dividend Gr. 3/5Y | 10.14% 10.46% | Current Ratio | 2.98 | EPS Q/Q | -26.06% | SMA20 | 3.04% | Beta | 0.90 | Target Price | 115.00 |
| Payout | 37.13% | Debt/Eq | 0.03 | Sales Q/Q | 2.72% | SMA50 | 4.30% | Rel Volume | 0.89 | Prev Close | 85.48 |
| Employees | 2,450 | LT Debt/Eq | 0.03 | Earnings | Nov 03 | SMA200 | 10.75% | Avg Volume | 196.87K | Price | 86.70 |
| IPO Date | May 13, 1998 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.45% 4.87% | Net Debt/EBITDA | -1.33 | Volume | 174,790 | Change | 1.43% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Apr-21-25 | Upgrade | Seaport Global | Neutral → Buy | $115 |
| Apr-12-19 | Downgrade | Keybanc | Overweight → Sector Weight | |
| Nov-14-17 | Upgrade | Johnson Rice | Hold → Accumulate | |
| Nov-09-17 | Downgrade | Monness, Crespi, Hardt | Buy → Neutral | |
| Aug-22-17 | Upgrade | Monness Crespi Hardt | Neutral → Buy | |
| Dec-19-16 | Downgrade | Monness Crespi Hardt | Buy → Neutral | |
| Apr-05-16 | Upgrade | Keybanc | Sector Weight → Overweight | |
| Feb-14-14 | Downgrade | CJS Securities | Market Outperform → Market Perform | |
| Nov-12-13 | Downgrade | Keybanc | Buy → Hold |
Innospec Inc., founded in 1938 as Octel Corp. and rebranded in January 2006, is a global company headquartered in Englewood, Colorado. It focuses on the creation, production, formulation, promotion, and distribution of unique chemical products. The company's operations span across the United States, the wider North American continent, the United Kingdom, continental Europe, and various international markets. Innospec's business is organized into distinct divisions. The Fuel Specialties segment provides a portfolio of specialized chemical additives engineered for various fuel applications. These crucial products are deployed in the functioning of engines for automobiles, maritime vessels, and aviation, as well as for electricity generators and heating oil systems. The Performance Chemicals division delivers sophisticated, technology-driven solutions designed to enhance customer processes or products. This unit primarily caters to sectors such as personal care, household products, agricultural chemicals, and metal recovery. Its Oilfield Services segment concentrates on developing and commercializing chemical solutions essential for fracturing, stimulating, and completing wells. This segment also supplies products that facilitate oil and gas extraction and prevent the loss of drilling mud during operations. Innospec sells its diverse range of products to a broad client base, including companies involved in oil and gas exploration and production, oil refining facilities, fuel producers and end-users, businesses in the personal care and home care industries, formulators of agrochemical and metal extraction products, and various other chemical and industrial enterprises.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,791 | 1,778 | 1,845 | 1,949 | 1,964 | 1,483 | 1,193 | 1,513 | 1,477 | |
| Cost of Goods Sold Incl. D&A | 1,300 | 1,286 | 1,303 | 1,358 | 1,377 | 1,049 | 850 | 1,047 | 1,042 | |
| Gross Profit | 491 | 492 | 543 | 591 | 587 | 435 | 343 | 466 | 435 | |
| Selling, General and Administrative Excl. Other | 295 | 285 | 314 | 388 | 361 | 267 | 237 | 281 | 261 | |
| Research and Development | 52 | 51 | 48 | 42 | 39 | 37 | 31 | 35 | 33 | |
| Other Operating Expense | 0 | 0 | 3 | 0 | -1 | -1 | 41 | 0 | 0 | |
| Operating Income | 144 | 156 | 178 | 162 | 187 | 132 | 34 | 150 | 134 | |
| Interest Expense | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 5 | 7 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -11 | -18 | -137 | 13 | -2 | 4 | 8 | 5 | 5 | |
| Net Income Before Taxes | 134 | 138 | 41 | 174 | 185 | 134 | 40 | 150 | 132 | |
| Income Taxes | 19 | 22 | 6 | 35 | 52 | 41 | 11 | 38 | 47 | |
| Consolidated Net Income | 114 | 117 | 36 | 139 | 133 | 93 | 29 | 112 | 85 | |
| Net Income From Continuing Operations | 115 | 117 | 36 | 139 | 133 | 93 | 29 | 112 | 85 | |
| Net Income | 114 | 117 | 36 | 139 | 133 | 93 | 29 | 112 | 85 | |
| EPS (Recurring) | 4.60 | 4.69 | 1.43 | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | |
| EPS (Basic, Before Extraordinaries) | 4.60 | 4.69 | 1.43 | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | |
| EPS (Diluted) | 4.59 | 4.67 | 1.42 | 5.56 | 5.32 | 3.75 | 1.16 | 4.54 | 3.45 | |
| EBITDA | 179 | 187 | 225 | 214 | 226 | 173 | 88 | 206 | 194 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.89 | 16.39 | 77.51 | 22.17 | 19.33 | 24.09 | 78.22 | 22.78 | 17.90 | |
| Price To Sales Ratio | 1.21 | 1.08 | 1.49 | 1.58 | 1.31 | 1.52 | 1.90 | 1.64 | 1.00 | |
| Gross Margin | 27.41 | 27.67 | 29.43 | 30.32 | 29.89 | 29.33 | 28.75 | 30.80 | 29.45 | |
| Operating Margin | 8.04 | 8.77 | 9.65 | 8.31 | 9.52 | 8.90 | 2.85 | 9.91 | 9.07 | |
| Net Margin | 6.37 | 6.58 | 1.95 | 7.13 | 6.77 | 6.27 | 2.43 | 7.40 | 5.75 | |
| Shares Outstanding | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 24 | 24 | |
| Market Capitalization | 2,168 | 1,914 | 2,752 | 3,081 | 2,572 | 2,259 | 2,268 | 2,483 | 1,482 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PADFIELD Larry | Director | Feb 27 '26 | Sale | 76.55 | 1,188 | 90,947 | 9,453 | Mar 06 |
| LANDLESS DAVID | Director | Feb 27 '26 | Sale | 76.55 | 1,188 | 90,947 | 7,632 | Mar 06 |
| Blackmore Milton C | Director | Feb 27 '26 | Sale | 76.55 | 1,188 | 90,947 | 10,530 | Mar 06 |
| Poccia Claudia | Director | Feb 27 '26 | Sale | 76.56 | 238 | 18,220 | 6,508 | Mar 06 |
| Cleminson Ian | EVP & CFO | Feb 27 '26 | Sale | 76.56 | 4,760 | 364,410 | 20,357 | Mar 06 |
| Jones David B. | SVP, GC & CCO | Mar 03 '26 | Sale | 75.64 | 1,028 | 77,758 | 14,693 | Mar 03 |
| PADFIELD Larry | Director | Feb 20 '26 | Sale | 81.84 | 1,030 | 84,296 | 8,508 | Feb 24 |
| Blackmore Milton C | Director | Feb 20 '26 | Option Exercise | 44.18 | 1,030 | 45,505 | 10,615 | Feb 24 |
| Blackmore Milton C | Director | Feb 20 '26 | Sale | 81.84 | 1,030 | 84,296 | 9,585 | Feb 24 |
| PADFIELD Larry | Director | Feb 20 '26 | Option Exercise | 44.18 | 1,030 | 45,505 | 9,538 | Feb 24 |
| PARRETTE LESLIE J | Director | Nov 14 '25 | Buy | 74.09 | 340 | 25,191 | 5,837 | Nov 17 |
| PARRETTE LESLIE J | Director | May 13 '25 | Sale | 90.63 | 446 | 40,421 | 5,497 | May 15 |
| Cleminson Ian | EVP & CFO | Mar 03 '25 | Sale | 100.98 | 4,275 | 431,679 | 15,858 | Mar 04 |
| BARNES CORBIN | SVP, Corporate Dev and IR | Feb 21 '25 | Option Exercise | 99.68 | 200 | 19,936 | 8,251 | Feb 27 |
| GRIFFIN HARDY LOUIS III | SVP, HUMAN RESOURCES | Feb 21 '25 | Option Exercise | 99.68 | 121 | 12,061 | 5,781 | Feb 27 |